In a newly released report from KLAS Research, a health care research firm, Surfacide UV Technology has received all “A” ratings for its Helios UV-C System. The report’s performance insights include product satisfaction, customer support, value, loyalty, culture and operations.
A sampling of organizations using Surfacide technology were surveyed, including large and small hospital health systems, academic health systems, standalone hospitals and clinics. Of those surveyed, top reasons for selecting Surfacide as their UV-C of choice were the patented triple emitter UV-C light technology, vendor support and technology/laser mapping features.
According to a press release, some notable insights and top key performance indicators include:
- “A” rating across the board for overall customer satisfaction
- “A+” when it comes to recommending Surfacide Helios System
- 100% indicate they would purchase again.
- Achieves desired disinfection outcomes
- Improves patient experience and satisfaction noted through HCAHPS scores
- High level of customer support drives customer satisfaction
“The KLAS report findings of straight A’s across the board are an honor and further validate what Surfacide clients have been saying for years,” said Gunner Lyslo, founder and CEO of Surfacide. “Our customers and the facilities we serve consistently receive best-in-class products, vendor support and results that improve lives and truly make an impact in the healthcare industry and beyond.”
